DEA’s Plan to Reschedule Cannabis: Implications and Insights
Jedediah Ande, Guillermo Artiles, Kelly Brennan, Gianni Garyfallos, Ryan Magee, William Palatucci McCarter & English, LLP Earlier this week, the Department of Justice proposed reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act. The move follows an August 2023 recommendation from the Department of Health and Human Services (HHS) to the U.S. Drug Enforcement Administration (DEA) […]